From bench to bedside – A mission for a healthy life

From bench to bedside – A mission for a healthy life

The DRFZ investigates the long‐term outcomes of rheumatic diseases, including the impact of current treatment options, in order to inform clinical decision making, identify unmet needs and improve health care. Biomedical research identifies the cells initiating and those driving rheumatic diseases, and the underlying molecular mechanisms. Our aim is the development of improved, personalised, at best curative therapies for patients with rheumatic diseases, and their rapid translation into clinical practice.

Mitchison Prize Ceremony and Hasinger Lecture
Online-Meeting via Zoom
1. Dezember 2020, 17.00 Uhr
4th German Mass Cytometry User Forum 20221 - online
Speed Dating with Science - Leibniz researchers answer questions on topics of everyday life - we are there!
January 21 & 22, 2021 - via Zoom

News

Unsere Mediathek